See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Your QuestionHave there been any advances in the treatment of this disease? What is its prevalence?
We have identified the following information that we hope you find helpful. If you still have questions, please contact us.
Questions on this page
Because collagenous gastritis is very rare and its cause is unknown, there is currently no established standard therapy for the condition. Various therapies have been attempted with limited success. These have included anti-secretary agents, steroids, iron supplementation, and hypoallergenic diets. Several other therapies have also been tested. A few affected people have shown improvement of symptoms, but no randomized, controlled trials have been performed. More studies are needed to establish a standard treatment strategy.
Last updated: 4/28/2015
Collagenous gastritis is a rare disorder first described in 1989. It has been reported that less than 50 cases of this condition have been published in the English language literature since it was first described.
Last updated: 10/24/2012
- Kamimura K, Kobayashi M, Sato Y, Aoyagi Y, Terai S. Collagenous gastritis: Review. World J Gastrointest Endosc. March 16, 2015; 7(3):265-273.
- Brain O, Rajaguru C, Warren B, Booth J, Travis S. Collagenous gastritis: reports and systematic review. Eur J Gastroenterol Hepatol. December 2009; 21(12):1419-1424.
- Rustagi T, Rai M, Scholes JV. Collagenous gastroduodenitis. J Clin Gastroenterol. October 2011; 45(9):794-799.